Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Drugs

Drugs


Company Last %CHNG Volume
ZIOPHARM Oncology Inc. (ZIOP) 2.02 18.13 2.51 M
Echo Therapeutics Inc. (ECTE) 0.55 14.58 0.57 M
MannKind Corporation (MNKD) 6.85 9.95 19.95 M
TrovaGene Inc. (TROV) 6.95 9.62 0.21 M
Ampio Pharmaceuticals Inc. (AMPE) 5.08 8.32 0.53 M
Redhill Biopharma Ltd (RDHL) 11.49 7.99 0.00 M
ProPhase Labs Inc. (PRPH) 1.58 7.48 0.09 M
Vivus (VVUS) 14.50 7.25 6.74 M
BioDelivery Sciences International Inc. (BDSI) 4.50 7.14 0.47 M
Cyclacel Pharmaceuticals Inc. (CYCC) 3.18 6.35 0.97 M
Company Last %CHNG Volume
Apricus Biosciences Inc. (APRI) 2.65 -19.70 5.30 M
Neuro-Hitech Incorporated (NHPI) 0.01 -15.79 0.01 M
Venaxis Inc (APPY) 1.36 -14.88 0.63 M
Cormedix Inc. (CRMD) 0.59 -9.49 0.11 M
China Pharma Holding Inc. (CPHI) 0.21 -7.79 0.02 M
TherapeuticsMD Inc (TXMD) 2.44 -7.22 0.08 M
Oxygen Biotherapeutics Inc. (OXBT) 4.15 -6.76 0.00 M
Cell Therapeutics Inc. (CTIC) 1.22 -5.43 0.88 M
Bacterin International Holdings Inc. (BONE) 0.74 -5.13 0.05 M
Prima Biomed Ltd. (PBMD) 2.45 -4.58 0.00 M
Company Last %CHNG Volume
Pfizer Inc (PFE) 29.11 -0.65 51.62 M
Elan Corp PLC (ELN) 12.36 2.66 30.24 M
Merck & Co Inc (MRK) 47.33 1.33 22.56 M
MannKind Corporation (MNKD) 6.85 9.95 19.95 M
Johnson & Johnson (JNJ) 87.21 -0.67 14.41 M
Bristol-Myers Squibb Company (BMY) 47.00 1.29 11.89 M
Warner Chilcott PLC (WCRX) 20.00 -1.23 10.96 M
Gilead Sciences Inc (GILD) 55.48 -0.80 10.76 M
Zoetis Inc (ZTS) 32.84 -2.12 9.01 M
Vivus (VVUS) 14.50 7.25 6.74 M
Company Last %CHNG Mkt Cap
Johnson & Johnson (JNJ) 87.21 -0.67 $248.8 B
Pfizer Inc (PFE) 29.11 -0.65 $204.1 B
Novartis AG (NVS) 73.82 -1.07 $183.4 B
Sanofi (SNY) 54.56 -0.89 $147.6 B
Merck & Co Inc (MRK) 47.33 1.33 $142.9 B
GlaxoSmithKline PLC (GSK) 52.73 -0.40 $142.1 B
Novo Nordisk A/S (NVO) 168.92 -0.37 $94.1 B
Gilead Sciences Inc (GILD) 55.48 -0.80 $86.1 B
Amgen Inc (AMGN) 105.62 1.04 $78.2 B
AbbVie Inc (ABBV) 46.59 -0.36 $73.7 B

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Market Update

04:31PM 05/23/13

NEW YORK (TheStreet) -- Major U.S. stock averages dropped Thursday after a choppy trading session, as investors worried the Federal Reserve would scale back stimulus and China could be headed for a slowdown.

A better-than-expected jobless claims report gave way to worries that the labor market was indeed improving and would encourage the Federal Reserve to taper its bond-buying program. Manufacturing data in China indicated an unexpected contraction in manufacturing activity in the country, culminating into the steepest decline for the Nikkei 225 in Japan since the aftermath of the tsunami and nuclear disaster in March 2011. The index closed down 7.3%.

"We had about a 3% intraday move to the downside from yesterday's high to today's low based upon what came out of the Fed yesterday," said Phil Orlando, chief equity market strategist at Federated Investors. Equities did retrace from their intraday lows by midday. "This market has gone vertically . . . and this is the most hated rally in the history of the stock market . . . and I expect down 3% some cash started to come into the market at the margin." ...

More

Brokerage Partners
Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Manage Newsletters

Top Rated Stocks Top Rated Funds Top Rated ETFs